Evidence map›Paper›PMID 32733958›Full record

ArticleBioMed research international2020

Expression of NANOG and Its Regulation in Oral Squamous Cell Carcinoma.

Gašper Grubelnik, Emanuela Boštjančič, Aleš Grošelj, Nina Zidar

Open access · hybridAbstract read
In one paragraph

Article in BioMed research international, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 39 citations in OpenAlex.

  1. Review
  2. Expression ofInternational journal of molecular sciences · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Epigenetic Regulation of Driver Genes in Testicular Tumorigenesis.International journal of molecular sciences · 2023
    Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Prognostic Relevance of CD4Biomedicines · 2021
    Article
  16. NANOG expression in human development and cancerogenesis.Experimental biology and medicine (Maywood, N.J.) · 2020
    Review
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Gašper GrubelnikInstitute of Pathology, Faculty of Medicine, University of Ljubljana, Korytkova 2, 1000 Ljubljana, Slovenia.ORCID https://orcid.org/0000-0001-5783-3327
Emanuela BoštjančičInstitute of Pathology, Faculty of Medicine, University of Ljubljana, Korytkova 2, 1000 Ljubljana, Slovenia.ORCID https://orcid.org/0000-0002-8091-4595
Aleš GrošeljDepartment of Otorhinolaryngology and Cervicofacial Surgery, University Medical Centre Ljubljana, Zaloška 2 and Faculty of Medicine, University of Ljubljana, Korytkova 2, 1000 Ljubljana, Slovenia.ORCID https://orcid.org/0000-0002-1623-3197
Nina ZidarInstitute of Pathology, Faculty of Medicine, University of Ljubljana, Korytkova 2, 1000 Ljubljana, Slovenia.ORCID https://orcid.org/0000-0001-6866-3220
University of Ljubljana · SI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundResults of previous studies suggest that NANOG may be an important prognostic biomarker in oral squamous cell carcinoma (OSCC), but there are contradictory results regarding NANOG expression patterns on mRNA and protein levels, and the mechanisms of its regulation are poorly understood. Our aim was to analyze the expression and diagnostic significance of NANOG in OSCC, and the possible mechanisms of its regulation, i.e., protein regulators on mRNA level (

methodsOur study included 120 patients with OSCC. Expression of NANOG protein and mRNA was analyzed using immunohistochemistry and qPCR. Expression of regulatory factors, miRNAs, and copy number variation was performed using qPCR. Methylation status of

resultsWe detected upregulation of

conclusionsOur findings confirm the diagnostic significance of NANOG in OSCC and provide information on NANOG expression patterns on both mRNA and protein levels. They also suggest that protein regulators and microRNAs might play a crucial role, whereas methylation of its promoter and copy number variation probably have a minor role in the regulation of NANOG expression in OSCC.

Indexed as

Gene Expression Regulation, NeoplasticAgedAged, 80 and overCarcinoma, Squamous CellDNA Copy Number VariationsDNA MethylationFemaleHumansKruppel-Like Factor 4Lymphatic MetastasisMicroRNAsMiddle AgedMouth NeoplasmsNanog Homeobox ProteinNeoplasm ProteinsPromoter Regions, GeneticKLF4 protein, humanKruppel-Like Factor 4MicroRNAsNanog Homeobox ProteinNeoplasm ProteinsRNA, Messenger

Identifiers

PMID32733958
PMCPMC7383335
OpenAlexW3043516685

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.